Technology

WynnBet confirmed Wednesday that it plans to cease online wagering in Massachusetts and Betr announced last week that it would not renew its temporary license to take bets in Massachusetts.

The founder of Framingham-based healthcare commercial intelligence firm Definitive Healthcare is back at the helm of the company on an interim basis, following the resignation of CEO and board member Robert Musslewhite.

Schwartz, who has experience leading companies through the public listing process, has been brought in to guide the company’s legal and financial functions as it seeks to further expand its customer base.

The Seattle-based retail giant bought two Friberg Parkway properties, along with a third facility in Grafton, for $26 million in 2022.

Cognex has announced Paul Todgham, its senior vice president of finance and chief financial officer, will depart the company in March.

Virtusa has signed a multi-year collaboration agreement with Seattle-based Amazon Web Services to allow Virtusa to open four artificial intelligence and data labs. 

Natick weight-loss firm Allurion Technologies has hired Brian Conyer to lead commercialization of its digital assets, including its newly launched commercial agreement with a German weight-loss group. 

Marlborough medical technology firm Boston Scientific has initiated a new clinical trial to study a treatment of persistent atrial fibrillation, an irregular rapid heart rhythm.

Bluejay Diagnostics in Acton is launching a clinical trial to study the efficacy of its Symphony System in patients with sepsis, a life-threatening complication from infection.

Regulating artificial intelligence, creating an agricultural disaster relief fund and boosting food security emerged as areas of focus that lawmakers could tackle in 2024 following a batch of committee votes.